Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial
Hannah Crepeault(University of British Columbia), M. Eugenia Socías(University of British Columbia), Evan Wood(University of British Columbia), Didier Jutras‐Aswad(Centre Hospitalier de l’Université de Montréal), Bernard Le Foll(Centre for Addiction and Mental Health), Paxton Bach(University of British Columbia), Ron Lim(University of Calgary), Lianping Ti(University of British Columbia)
Cited by 0
Related Papers
Genetics of dopamine receptors and drug addiction: a comprehensive review
|Behavioural Pharmacology|2009|396
Tobacco and nicotine use
|Nature Reviews Disease Primers|2022|293
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Identification of Dopamine D1–D3 Receptor Heteromers
|Journal of Biological Chemistry|2008|230
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150